Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

Clover Flex Sihuan Pharmaceutical's exclusive agent for botulinum toxin Letibao is approved for marketing by NMPA Vertex's Kalydeco for cystic fibrosis is close to approval in the EU Two imported new ...

INR:6560. blackjack real Bayer acquires AskBio for $4 billion to expand cell and gene therapy pipeline Vertex's Kalydeco for cystic fibrosis is close to approval i ...

INR:8074. france vs austria betting tips Science: There is scientific evidence that staying up late makes you stupid!

The top 10 pharmaceutical stocks are released! Hengrui Medicine aims to hit a market value of 370 billion yuan ASH | BTK inhibitor development trends: Eli Lilly, BeiGene, and AZ announce clinical resu ...

Nature: Large-scale screening discovered 21 existing anti-new coronavirus drugs! Sanofi expands collaboration with US$2.3 billion to develop mRNA vaccines for infectious diseases! Vertex's Kalydeco fo ...

INR:3725. across the unlverse fiona apple Will the next round of centralized procurement include Caronin, Enbipu, and Shupushen? "Fake stock" ST K ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...